Swedish snuff (snus) dipping, cigarette smoking, and risk of peripheral artery disease: a prospective cohort study.

Sci Rep

Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, 17177, Stockholm, Sweden.

Published: July 2022

Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unknown whether smokeless tobacco, such as Swedish snuff (snus), is also associated with this disease. We used data from the Cohort of Swedish Men including 24,085 men. Individuals were grouped into never, past, and current snus dippers as well as never, past quitting ≥ 10 years, past, quitting < 10 years, and current smokers. Incident PAD cases were defined by linkage of the cohort with the Swedish National Patient Register. Cox proportional hazards regression was used to analyze the data. Over a mean follow-up period of 9.1 years (from July 1, 2009 to December 31, 2019), 655 incident PAD cases were ascertained. Cigarette smoking but not Swedish snus dipping was associated with an increased risk of PAD. Compared with never snus dippers, the hazard ratio of PAD was 0.95 (95% confidence interval [CI] 0.73-1.24) for past snus dippers and 0.88 (95% CI 0.66-1.17) for current snus dippers. Compared to never smokers, the hazard ratio of PAD was 1.38 (95% CI 1.14-1.68) for past smoker who stopped smoking for ≥ 10 years, 2.61 (95% CI 1.89-3.61) for past smoker who stopped smoking for < 10 years, and 4.01 (95% CI 3.17, 5.08) for current smoker. In conclusion, cigarette smoking but not Swedish snus dipping increases the risk of PAD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287299PMC
http://dx.doi.org/10.1038/s41598-022-16467-xDOI Listing

Publication Analysis

Top Keywords

swedish snuff
8
snuff snus
8
smoking risk
8
peripheral artery
8
artery disease
8
snus dipping
4
dipping cigarette
4
cigarette smoking
4
risk peripheral
4
disease prospective
4

Similar Publications

Tobacco use is not only a major risk factor for morbidity and mortality but also associated with alcohol misuse. While personality traits may be driving this association, the psychoactive component of tobacco, nicotine, may also be a major risk factor. The aim with this study was to further assess the prospective association between tobacco use and alcohol consumption, with special emphasis on the role of the tobacco product used (cigarettes and Swedish snus), frequency of use, and gender.

View Article and Find Full Text PDF

The more smoking the more cataract: A study on smoking, snus use and cataract in a Swedish population.

Acta Ophthalmol

February 2025

Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Purpose: To examine the prevalence of self-reported cataract and cataract surgery, and the incidence of cataract surgery, in relation to smoking and use of the moist smokeless tobacco product snus.

Methods: In 2014/2015, individuals born in 1951 (n = 18 055) in the Västra Götaland County, Sweden, were invited to participate. Of these, 9743 (54%) accepted participation and 9316 (52%) remained after exclusion criteria were applied.

View Article and Find Full Text PDF
Article Synopsis
  • In Sweden, there has been a significant shift from smoking cigarettes to using snus, a low-toxicity oral tobacco product.
  • Snus poses minimal health risks compared to cigarettes, contributing to Sweden’s low smoking-related mortality rates among males in Europe.
  • Research indicates that approximately 3,000 lives per year have been saved in Sweden due to the use of snus, based on comparisons with other countries and a hypothetical scenario without snus.
View Article and Find Full Text PDF

Objectives: To investigate the association of early snus use initiation (≤15 years of age) with asthma and asthma symptoms.

Design: Cross-sectional analysis of a population-based cohort.

Setting: Study centres in Norway, Sweden, Iceland, Denmark and Estonia, from 2016 to 2019.

View Article and Find Full Text PDF

toxicology research has accelerated with the use of , computational approaches and human tissue systems, facilitating major improvements evaluating the safety and health risks of novel consumer products. Innovation in molecular and cellular biology has shifted testing paradigms, with less reliance on low-throughput animal data and greater use of medium- and high-throughput cellular screening approaches. These new approach methodologies (NAMs) are being implemented in other industry sectors for chemical testing, screening candidate drugs and prototype consumer products, driven by the need for reliable, human-relevant approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!